Curebound Cancer Challenge Comes to UC San Diego |
Join us on August 2, 2025, at UC San Diego’s RIMAC Field to ride, walk, run or spin alongside cancer patients, survivors, physicians and supporters. Since its inception in 2013, the event has raised over $24.5 million in critical funds that support cancer research in San Diego. Learn More>>
|
Now Live: Clinical Trials Patient Appreciation Day Video Recap |
Explore reflections from patients and physicians at Moores Cancer Center, highlighting the critical role of clinical research in advancing cancer care. Their stories underscore the impact of scientific discovery, collaboration and the resilience at the heart of translational medicine. Watch Now>>
|
2025 Cancer Systems Biology Consortium (CSBC) Junior Investigator Meeting |
The 2025 Cancer Systems Biology Consortium (CSBC) Junior Investigator Meeting will be held a day prior to the 2025 CSBC Annual Meeting, offering junior investigators a platform to present their work, connect with peers and build cross-disciplinary collaborations. Alex Wenzel, PhD, former Moores Cancer Center trainee and current postdoctoral fellow in the Mesirov Lab, is serving as co-chair of the meeting. Learn More>>
|
36th Annual Usha Mahajani Symposium on Molecular Medicine: 3D Modeling of Tumor Biology |
The 36th annual symposium will take place on September 5, 2025, at the Conrad T. Prebys Auditorium at Salk Institute for Biological Sciences. The event serves as an excellent opportunity for scientists in industry and academia alike to network and learn about leading-edge research in the field. Learn More>>
|
|
|
| Mechanism of cytarabine-induced neurotoxicity |
Anjana Rao, PhD (Structural and Functional Genomics)
|
|
|
| Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non-Small Cell Lung Cancer After Platinum-Based Chemotherapy and Immunotherapy |
Journal of Clinical Oncology
|
Kathryn Gold, MD (Solid Tumor Therapeutics)
|
|
|
| Multimodal Investigation of Angiogenesis and Its Prevention by Small Compounds in a Zebrafish Cancer Model |
David Traver, PhD (Hematologic Malignancies)
|
|
|
FEATURED FUNDING OPPORTUNITIES
|
National Institutes of Health (NIH) Director’s Transformative Research Awards (R01 Clinical Trial Optional) |
The NIH Director's Transformative Research Award supports collaborative investigative teams or individual scientists who propose unusually bold and innovative research projects, which, if successful, would have a major impact in a broad area of relevance to the NIH.
Submission Deadline: Wednesday, September 03, 2025
|
Cancer Prevention Fellowship Program (CPFP) |
The Cancer Prevention fellowship is an opportunity to spend up to four years conducting full-time research at the NCI. NCI offers competitive stipends that are determined by the applicant's degree and years of relevant postdoctoral experience. Stipend levels increase with the number of years of postdoctoral experience. Annual increases may be given. Stipends are subject to change depending on Federal guidelines and funding availability.
Application Deadline: September 12, 2025
|
|
|
CLINICAL TRIALS OFFICE (CTO) |
|
|
No newly opened clinical trials.
|
|
|
|
